(Q54073250)
Statements
Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. (English)
S E Singletary
A U Buzdar
R L Theriault
D J Booser
V Valero
N Ibrahim
T L Smith
L Asmar
D Frye
N Manuel
S W Kau
M McNeese
E Strom
K Hunt
F Ames
G N Hortobagyi
1 November 1999
17
11
3412-3417